Role of foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma

American Journal of Surgical Pathology

Volumn 36, Issue 7, 2012, Pages 980-986

  Mathai, Alka Mary ^a   Kapadia, Monesh J ^a   Alexander, Jacob ^a   Kernochan, Lauren E ^a   Swanson, Paul E ^a   Yeh, Matthew M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Foxp3 + Tregs; hepatocellular carcinoma; histopathology; intratumoral lymphocytes; prognosis; survival

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL DIFFERENTIATION; CELL NUCLEUS; CHEMISTRY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TIME; TREATMENT OUTCOME; TUMOR ASSOCIATED LEUKOCYTE; TUMOR RECURRENCE; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD3; ANTIGENS, CD8; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL NUCLEUS; DISEASE-FREE SURVIVAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; WASHINGTON;

EID: 84863332648     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824e9b7c     Document Type: Article

References (38)

1. Alsina AE. Liver transplantation for hepatocellular carcinoma. Cancer Control. 2010;17:83-86.
2. Baccarani U, Isola M, Adani GL, et al. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma. Transpl Int. 2008;21:247-254. (Pubitemid 351197349)
3. Bohling SD, Allison KH. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod Pathol. 2008;21:1527-1532.
4. Bui JD, Uppaluri R, Hsieh CS, et al. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 2006;66:7301-7309. (Pubitemid 44197712)
5. Burt AD, Portmann BC, Ferrell LD. MacSween's Pathology of the Liver. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 2007.
6. American Joint Committee on Cancer. Chapter 18: Liver. In: Edge SB, Byrd DR, Compton CC, et al, eds. Cancer Staging Handbook. 7th ed. New York: Springer; 2010:237-245.
7. Cao M, Cabrera R, Xu Y, et al. Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells. Lab Invest. 2007;87:582-590. (Pubitemid 46788787)
8. Facciuto ME, Koneru B, Rocca JP, et al. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol. 2008;15:1383-1391.
9. Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology. 2007;132:2328-2339. (Pubitemid 46890865)
10. Gao Q, Qiu SJ, Fan J, et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25:2586-2593. (Pubitemid 47041232)
11. Hoechst B, Ormandy LA, Ballmaier M, et al. A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology. 2008;135:234-243. (Pubitemid 351899008)
12. Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13:902-911. (Pubitemid 46340366)
13. Kojiro M. Pathology of Hepatocellular Carcinoma. Oxford, UK: Blackwell publishing Ltd.; 2006.
14. Kim HR, Cheon SH, Rha SY, et al. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Asia Pac J Clin Oncol. 2011;7:258-269.
15. Lee KK, Kim DG, Moon IS, et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol. 2010;101:47-53.
16. Li L, Li S, Min J, et al. Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells. Immunol Lett. 2007;114:38-45. (Pubitemid 47625596)
17. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699. (Pubitemid 26079803)
18. Michel J, Suc B, Montpeyroux F, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol. 1997;26:1274-1280. (Pubitemid 27346640)
19. Onizuka S, Tawara I, Shimizu J, et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 1999;59:3128-3133. (Pubitemid 29316012)
20. Ormandy LA, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T-cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 2005;65:2457-2464. (Pubitemid 40490158)
21. Regimbeau JM, Abdalla EK, Vauthey JN, et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;85:36-41. (Pubitemid 38036738)
22. Sasaki A, Tanaka F, Mimori K, et al. Prognostic value of tumorinfiltrating Foxp3+ regulatory T cells in patients with hepatocellular carcinoma. Eur J Surg Oncol. 2008;34:173-179.
23. Sato E, Olson SH, Ahn J, et al. Intraepithelial CD8+ tumorinfiltrating lymphocytes and a high CD8 +regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005;102:18538-18543. (Pubitemid 43011261)
24. Schreibman IR, Bejarano P, Martinez EJ, et al. Very late recurrence of hepatocellular carcinoma after liver transplantation: case report and literature review. Transplant Proc. 2006;38:3140-3143. (Pubitemid 44737896)
25. Shah SA, Cleary SP, Wei AC, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007;141:330-339. (Pubitemid 46371307)
26. Shen X, Li N, Li H, et al. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2010;136: 1745-1754.
27. Shen Z, Zhou S, Wang Y, et al. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3 +CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol. 2010;136:1585-1595.
28. Strauss L, Bergmann C, Whiteside TL. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer. Int J Cancer. 2007;121:2473-2483. (Pubitemid 350022417)
29. Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med. 2001;194:823-832. (Pubitemid 32983017)
30. Unitt E, Marshall A, Gelson W, et al. Tumor lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol. 2006;45:246-253.
31. Unitt E, Rushbrook SM, Marshall A. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology. 2005;41:722-730. (Pubitemid 40462933)
32. Xu D, Fu J, Jin L, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol. 2006;177:739-747. (Pubitemid 43939189)
33. Yang XH, Yamagiwa S, Ichida T, et al. Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. J Hepatol. 2006;45:254-262.
34. Yang ZQ, Yang ZY, Zhang LD, et al. Increased liver-infiltrating CD8+Foxp3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Hum Immunol. 2010;71: 1180-1186.
35. Yu P, Lee Y, Liu W, et al. Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005;201:779-791. (Pubitemid 40395122)
36. Zhou J, Ding T, Pan W, et al. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients. Int J Cancer. 2009;125:1640-1648.
37. Zhou L, Rui J, Ye D, et al. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection. World J Surg. 2008;32:1748-1756.
38. Zimmerman MA, Ghobrial RM, Tong MJ, et al. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators. Arch Surg. 2008;143:182-188; discussion 188. (Pubitemid 351281631)